期刊文献+

哌拉西林与他唑巴坦联合应用方案治疗110例老年呼吸道感染的临床疗效观察 被引量:3

下载PDF
导出
摘要 目的评价哌拉西林与他唑巴坦联合应用方案治疗老年呼吸道感染的临床疗效及安全性。方法 110例老年呼吸道感染患者均给予哌拉西林与他唑巴坦联合应用方案治疗,治疗期间进行全程监护。结果治疗后,患者白细胞计数(WBC)、中性粒细胞百分比、血乳酸低于治疗前,且血红蛋白水平高于治疗前,差异具有统计学意义(P<0.05);治愈率为54.55%,有效率为37.27%,总有效率为91.82%;病原体清除率为89.36%(84/94);不良反应发生率为8.18%。结论哌拉西林与他唑巴坦联合应用方案治疗老年呼吸道感染疗效较好,且安全可靠,值得临床推广。
作者 万伟 杭星
出处 《中国实用医药》 2016年第1期121-122,共2页 China Practical Medicine
  • 相关文献

参考文献6

二级参考文献44

  • 1DRUSANO GL, SCHIMPFF SC,HEWITT WL. The acylampillins : mezocillin, piperacillin, and azlocillin [ J ]. Rev Infect Dis, 1984,6:13 -32.
  • 2LISTER PD, PREVAN AM, SANDERS CC. Importance of β-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam [ J ]. Aatimicrob Agents Chemother, 1997,41 (4) :721 -727.
  • 3BAUERNFEIND H, GRIMM W, KLIETMANN W, et al. The influence of sulbactam on the in vitro activity of mezlocilin, piperacillin and cefotaxime [J]. Inter Antimicrob Agents, 1996,6 (Suppl) :S15 - S26.
  • 4PERRY CM, MARKHAM A. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections [ J ]. Drugs, 1999, 57 (5) :805 - 843.
  • 5FRANK U, MUTTER J, SCHMIDT-EISENLOHR E, et al. Comparative in vitro activity of piperacillin, piperacillin-sulbactam and piperacillin-tazobactam against nosocomial pathogens isolated from intensive care patients [J].Clin Microbiol Infect, 2003,9 (11) : 1128 - 1132.
  • 6EI Solh AA, Niederman MS, Drinka P. Nursing home-acquired pneumonia:a review of risk factors and therapeutic approaches [J]. Curr Med Res Opin,2010,26(12):2707-2714.
  • 7Kollef MH, Morrow I.E, Baughman RP,et al. Health care-associated pneumonia (HCAP) :a critical appraisal to improve'identification, management, and outcomes-proceedings of the HCAP Summit[J]. Clin Infect Dis, 2008,46 ( Suppl 4) : S296-S338.
  • 8Polverino E,Torres A. Current perspective of the HCAP problem: is it CAP or is it HAP[J]. Semin Respir Crit Care Med,2009,30 (2) :239-248.
  • 9EI-Solh AA,Alhajhusain A. Update on the treatment of Pseudomonas aeruginosa pneumonia[J]. J Antimicrob Chemother,2009, 64(2) :229 238.
  • 10Johnson CA,Kelloway JS,Tonelli A,et al.Single-does pharmackinetics of piperacillin and Tazobactam in patients with renal disease[J].Clin Pharmacol Ther,1992,51(1):32-36.

共引文献32

同被引文献24

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部